GFC Life Science Co., Ltd.

388610KOSDAQChemicals and chemical products

GFC Life Science Co., Ltd. (388610, KOSDAQ) reported KRW 18bn revenue in 2025.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
2023
2024172-62011Separate
202518013424Separate

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
2023
202410.1%-35.4%54.4%-54.6%
20252.2%3.1%70.3%2.3%

Revenue moved 5.4% between 2023 and 2025.

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 28bn
Close priceKRW 5,340
Listed shares5,325,383
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

Workforce — a side measure, not the main one

Employees (2025)86
Women64 (74.4%)
Average tenure4.3 years
Annual pay, menKRW 62,272,727
Annual pay, womenKRW 42,921,875
Pay ratio, women to men68.9%

Other companies in Chemicals and chemical products

172 listed companies file under this classification. Showing 12.

See the whole Chemicals and chemical products list →